Hollsteen
← HPE

Research and development

Flow – sum over the period · $M

QuartersFiscal years

$MResearch and development · Q1 FY2016: $585M · 10-Q 0001047469-16-010994 filed Mar 10, 2016Research and development · Q2 FY2016: $621M · 10-Q 0001628280-17-006325 filed Jun 8, 2017Research and development · Q3 FY2016: $551M · 10-Q 0001628280-17-009143 filed Sep 7, 2017Research and development · Q4 FY2016: −$40.0M · derived · 10-K 0001628280-17-012383 filed Dec 15, 2017Research and development · Q1 FY2017: $356M · 10-Q 0001628280-18-003043 filed Mar 9, 2018Research and development · Q2 FY2017: $376M · 10-Q 0001628280-18-007715 filed Jun 7, 2018Research and development · Q3 FY2017: $390M · 10-Q 0001628280-18-011596 filed Sep 4, 2018Research and development · Q4 FY2017: $364M · 10-K 0001628280-18-015054 filed Dec 12, 2018Research and development · Q1 FY2018: $389M · 10-Q 0001628280-19-002482 filed Mar 5, 2019Research and development · Q2 FY2018: $403M · 10-Q 0001645590-19-000017 filed May 31, 2019Research and development · Q3 FY2018: $435M · 10-Q 0001645590-19-000030 filed Aug 30, 2019Research and development · Q4 FY2018: $439M · 10-K 0001628280-18-015054 filed Dec 12, 2018Research and development · Q1 FY2019: $466M · 10-Q 0001628280-19-002482 filed Mar 5, 2019Research and development · Q2 FY2019: $457M · 10-Q 0001645590-19-000017 filed May 31, 2019Research and development · Q3 FY2019: $481M · 10-Q 0001645590-19-000030 filed Aug 30, 2019Research and development · Q4 FY2019: $438M · derived · 10-K 0001645590-20-000056 filed Dec 10, 2020Research and development · Q1 FY2020: $485M · 10-Q 0001645590-20-000009 filed Mar 9, 2020Research and development · Q2 FY2020: $450M · 10-Q 0001645590-20-000025 filed Jun 2, 2020Research and development · Q3 FY2020: $455M · 10-Q 0001645590-20-000041 filed Sep 3, 2020Research and development · Q4 FY2020: $484M · derived · 10-K 0001645590-21-000068 filed Dec 10, 2021Research and development · Q1 FY2021: $468M · 10-Q 0001645590-21-000016 filed Mar 4, 2021Research and development · Q2 FY2021: $503M · 10-Q 0001645590-21-000041 filed Jun 3, 2021Research and development · Q3 FY2021: $506M · 10-Q 0001645590-21-000055 filed Sep 3, 2021Research and development · Q4 FY2021: $502M · derived · 10-K 0001645590-22-000071 filed Dec 8, 2022Research and development · Q1 FY2022: $504M · 10-Q 0001645590-22-000016 filed Mar 3, 2022Research and development · Q2 FY2022: $517M · 10-Q 0001645590-22-000032 filed Jun 3, 2022Research and development · Q3 FY2022: $509M · 10-Q 0001645590-22-000052 filed Sep 1, 2022Research and development · Q4 FY2022: $515M · derived · 10-K 0001645590-23-000117 filed Dec 22, 2023Research and development · Q1 FY2023: $623M · 10-Q 0001645590-23-000035 filed Mar 7, 2023Research and development · Q2 FY2023: $570M · 10-Q 0001645590-23-000066 filed Jun 2, 2023Research and development · Q3 FY2023: $578M · 10-Q 0001645590-23-000087 filed Sep 1, 2023Research and development · Q4 FY2023: $578M · derived · 10-K 0001645590-24-000139 filed Dec 19, 2024Research and development · Q1 FY2024: $582M · 10-Q 0001645590-24-000069 filed Mar 5, 2024Research and development · Q2 FY2024: $590M · 10-Q 0001645590-24-000098 filed Jun 5, 2024Research and development · Q3 FY2024: $547M · 10-Q 0001645590-24-000119 filed Sep 5, 2024Research and development · Q4 FY2024: $527M · derived · 10-K 0001645590-25-000130 filed Dec 18, 2025Research and development · Q1 FY2025: $475M · 10-Q 0001645590-25-000039 filed Mar 7, 2025Research and development · Q2 FY2025: $540M · 10-Q 0001645590-25-000068 filed Jun 4, 2025Research and development · Q3 FY2025: $622M · 10-Q 0001645590-25-000101 filed Sep 4, 2025Research and development · Q4 FY2025: $881M · derived · 10-K 0001645590-25-000130 filed Dec 18, 2025Research and development · Q1 FY2026: $744M · 10-Q 0001645590-26-000032 filed Mar 10, 2026Research and development · Q2 FY2026: $922M · 10-Q 0001645590-26-000055 filed Jun 2, 2026Research and development · Q3 FY2026: $1.2B · 10-Q 0001645590-26-000080 filed Sep 3, 20264811,158585Q1 FY2016Q3 FY2026Q3 FY2019
$MResearch and development · Q3 FY2018: $435M · 10-Q 0001645590-19-000030 filed Aug 30, 2019Research and development · Q4 FY2018: $439M · 10-K 0001628280-18-015054 filed Dec 12, 2018Research and development · Q1 FY2019: $466M · 10-Q 0001628280-19-002482 filed Mar 5, 2019Research and development · Q2 FY2019: $457M · 10-Q 0001645590-19-000017 filed May 31, 2019Research and development · Q3 FY2019: $481M · 10-Q 0001645590-19-000030 filed Aug 30, 2019Research and development · Q4 FY2019: $438M · derived · 10-K 0001645590-20-000056 filed Dec 10, 2020Research and development · Q1 FY2020: $485M · 10-Q 0001645590-20-000009 filed Mar 9, 2020Research and development · Q2 FY2020: $450M · 10-Q 0001645590-20-000025 filed Jun 2, 2020481450435485Q3 FY2018Q2 FY2020Q3 FY2019
Q3 FY2019
481$M
All values (43)
PeriodValue ($M)Status
Q3 FY20261,158reported
Q2 FY2026922reported
Q1 FY2026744reported
Q4 FY2025881derived
Q3 FY2025622reported
Q2 FY2025540reported
Q1 FY2025475reported
Q4 FY2024527derived
Q3 FY2024547reported
Q2 FY2024590reported
Q1 FY2024582reported
Q4 FY2023578derived
Q3 FY2023578reported
Q2 FY2023570reported
Q1 FY2023623reported
Q4 FY2022515derived
Q3 FY2022509reported
Q2 FY2022517reported
Q1 FY2022504reported
Q4 FY2021502derived
Q3 FY2021506reported
Q2 FY2021503reported
Q1 FY2021468reported
Q4 FY2020484derived
Q3 FY2020455reported
Q2 FY2020450reported
Q1 FY2020485reported
Q4 FY2019438derived
Q3 FY2019481reported
Q2 FY2019457reported
Q1 FY2019466reported
Q4 FY2018439reported
Q3 FY2018435reported
Q2 FY2018403reported
Q1 FY2018389reported
Q4 FY2017364reported
Q3 FY2017390reported
Q2 FY2017376reported
Q1 FY2017356reported
Q4 FY2016−40derived
Q3 FY2016551reported
Q2 FY2016621reported
Q1 FY2016585reported

CSV with all sources · Technical ID: rnd

More metrics for HPE

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$481M
Period
Q3 FY2019, ended Jul 31, 2019 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Aug 30, 2019 · 0001645590-19-000030
Location
us-gaap:ResearchAndDevelopmentExpense
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$481MAug 30, 201910-Q 0001645590-19-000030reported · confidence 1. · current